University of Virginia
Charlottesville, Virginia, 22908-0717, United States
NCT Number: NCT06184737
The proposed pilot randomized controlled trial (RCT) will enroll 24 Black adults. The overall goal is to examine the preliminary efficacy of iSIPsmarter in a 2 group [iSIPsmarter vs. static Patient Education (PE) website] by 4 assessment (Pre, 3-, 6- and 18-month follow-up) design. The generated pilot data will allow us to better understand efficacy and engagement outcomes among Black participants. We anticipate trends that iSIPsmarter will be more efficacious at reducing SSB consumption than a PE website at post assessment.
This study is active but is not currently recruiting participants.
18 year–110 year
All sexes
Interventional
Not applicable
Charlottesville, Virginia, 22908-0717, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
iSIPsmarter is a technology-based behavioral and health literacy intervention. It is comprised of six Internet-delivered Cores, an integrated short message service (SMS) strategy to engage users in tracking SSB behaviors, and the incorporation of a cellular enabled scale for in-home weight tracking. Participants will be prompted (via email or text) to self-monitor their sugar-sweetened beverage intake. iSIPsmarter is a highly interactive, structured, and self-guided program that uses strategies previously proven to promote behavior change. iSIPsmarter also incorporates a stepped care approach to re-engage users who struggle to complete components.
The PE website will include scientifically accurate information that is typical of nutrition education websites and will include information about SSB recommendations, types of SSB and portion size, SSB-related health risks, energy balance information, identifying personal motivators and barriers to reducing SSB intake, interpreting SSB nutrition labels, and recognizing media influences and misclaims in SSB advertisements, as well as printable forms to track SSB and weight. Unlike iSIPsmarter, the content will not be tailored and will be presented all at once.
Time frame: Baseline, 9-weeks (immediate-post follow-up)
Measured using the Beverage Questionnaire 15 (BEVQ-15)
Time frame: Baseline, 9-weeks (immediate-post follow-up), 6-months, 18 months
2 unannounced recalls (one weekend and one weekday) using state-of-the-art Nutrition Data System for Research (NDSR) software and multiple pass methods. HEI indicators will be extracted from the NDSR system and examined for changes in the total HEI score, on a 100-point continuous scale (higher scores reflective higher diet quality).
Time frame: Baseline, 9-weeks (immediate-post follow-up), 6-months, 18 months
Cellular enabled in-home ©BodyTrace digital scale
Time frame: Baseline, 9-weeks (immediate-post follow-up), 6-months, 18 months
Using the Center's for Disease (CDC) Healthy Days Core Module
Time frame: Baseline, 6-months, 18 months
Measured using the BEVQ-15
University of Virginia
Other
iSIPsmarter: A Pilot RCT to Evaluate a Technology-based Behavioral Intervention to Reduce Sugary Beverages Among Black Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05030753
Behavior, Behavior, Animal
Charlottesville, Virginia, United States
View Trial DetailsNCT07104669
Athlete Foot, Bacterial Infections and Mycoses
San Vicent del Raspeig, Alicante, Spain
View Trial DetailsNCT06898918
Behavior, Behavior, Animal
Cairo, Egypt
View Trial DetailsNCT05394779
Behavior, Behavior, Animal
Milan, Italy
View Trial Details